0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dermal Filler and Botolinum Toxin Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-18X8130
Home | Market Reports | Health| Pharmacy
Global Dermal Filler and Botolinum Toxin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Dermal Filler and Botolinum Toxin Market Research Report 2024

Code: QYRE-Auto-18X8130
Report
January 2024
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dermal Filler and Botolinum Toxin Market Size

The global Dermal Filler and Botolinum Toxin market was valued at US$ 12050 million in 2023 and is anticipated to reach US$ 30390 million by 2030, witnessing a CAGR of 13.9% during the forecast period 2024-2030.

Dermal Filler and Botolinum Toxin Market

Dermal Filler and Botolinum Toxin Market

This report studies the dermal filler and botolinum toxin market. Dermal filler and botolinum toxin can be used for the cosmetic treatment of facial lines, and the rejuvenation of skin and underlying tissues.
Demand in the dermal fillers and botulinum toxin market will continue to remain strong, offsetting any industry margincompression.Additionally, increasing research & development(R&D) initiatives to extend the therapeutic botulinumapplications of botulinum toxin and a rising number of cosmetic issues are some of the key drivers of the dermal fillers and botulinum toxin market. Botulinum toxin is a non-invasive cosmetic procedure, which is used to treat a wide variety of cosmetic issues, includingforehead creases and fine lines on the face. Due to its minimal pain and downtime, as well as its long-lasting effects,botulinum toxin treatments are becoming more popular among patients getting facelfts. As it has few side effects andcan be used several times a year for maximum outcomes, botulinum toxin has received particularly positivereviews. This factor would further boost the sale of botulinum toxin treatments in the forecast period.
This report aims to provide a comprehensive presentation of the global market for Dermal Filler and Botolinum Toxin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermal Filler and Botolinum Toxin.

Report Scope

The Dermal Filler and Botolinum Toxin market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermal Filler and Botolinum Toxin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermal Filler and Botolinum Toxin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Dermal Filler and Botolinum Toxin Market Report

Report Metric Details
Report Name Dermal Filler and Botolinum Toxin Market
Accounted market size in 2023 US$ 12050 million
Forecasted market size in 2030 US$ 30390 million
CAGR 13.9%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Hyaluronic Acid Based Fillers
  • Non-Hyaluronic Acid Based Fillers
  • Botulinum Toxin
Segment by Application
  • Aesthetic Restoration
  • Wrinkle Reduction
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Allergan, Galderma, Merz Pharma GmbH & Co. KGaA, Anika Therapeutics, Suneva Medical, Contura, HUGEL, Grex Pharma, Daewoong Pharmaceuticals, Medy-Tox, TEOXANE Laboratories, SciVision Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dermal Filler and Botolinum Toxin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dermal Filler and Botolinum Toxin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Dermal Filler and Botolinum Toxin Market growing?

Ans: The Dermal Filler and Botolinum Toxin Market witnessing a CAGR of 13.9% during the forecast period 2024-2030.

What is the Dermal Filler and Botolinum Toxin Market size in 2030?

Ans: The Dermal Filler and Botolinum Toxin Market size in 2030 will be US$ 30390 million.

Who are the main players in the Dermal Filler and Botolinum Toxin Market report?

Ans: The main players in the Dermal Filler and Botolinum Toxin Market are Allergan, Galderma, Merz Pharma GmbH & Co. KGaA, Anika Therapeutics, Suneva Medical, Contura, HUGEL, Grex Pharma, Daewoong Pharmaceuticals, Medy-Tox, TEOXANE Laboratories, SciVision Biotech

What are the Application segmentation covered in the Dermal Filler and Botolinum Toxin Market report?

Ans: The Applications covered in the Dermal Filler and Botolinum Toxin Market report are Aesthetic Restoration, Wrinkle Reduction

What are the Type segmentation covered in the Dermal Filler and Botolinum Toxin Market report?

Ans: The Types covered in the Dermal Filler and Botolinum Toxin Market report are Hyaluronic Acid Based Fillers, Non-Hyaluronic Acid Based Fillers, Botulinum Toxin

1 Dermal Filler and Botolinum Toxin Market Overview
1.1 Product Overview and Scope of Dermal Filler and Botolinum Toxin
1.2 Dermal Filler and Botolinum Toxin Segment by Type
1.2.1 Global Dermal Filler and Botolinum Toxin Market Value Comparison by Type (2024-2030)
1.2.2 Hyaluronic Acid Based Fillers
1.2.3 Non-Hyaluronic Acid Based Fillers
1.2.4 Botulinum Toxin
1.3 Dermal Filler and Botolinum Toxin Segment by Application
1.3.1 Global Dermal Filler and Botolinum Toxin Market Value by Application: (2024-2030)
1.3.2 Aesthetic Restoration
1.3.3 Wrinkle Reduction
1.4 Global Dermal Filler and Botolinum Toxin Market Size Estimates and Forecasts
1.4.1 Global Dermal Filler and Botolinum Toxin Revenue 2019-2030
1.4.2 Global Dermal Filler and Botolinum Toxin Sales 2019-2030
1.4.3 Global Dermal Filler and Botolinum Toxin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dermal Filler and Botolinum Toxin Market Competition by Manufacturers
2.1 Global Dermal Filler and Botolinum Toxin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dermal Filler and Botolinum Toxin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dermal Filler and Botolinum Toxin Average Price by Manufacturers (2019-2024)
2.4 Global Dermal Filler and Botolinum Toxin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dermal Filler and Botolinum Toxin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dermal Filler and Botolinum Toxin, Product Type & Application
2.7 Dermal Filler and Botolinum Toxin Market Competitive Situation and Trends
2.7.1 Dermal Filler and Botolinum Toxin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dermal Filler and Botolinum Toxin Players Market Share by Revenue
2.7.3 Global Dermal Filler and Botolinum Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dermal Filler and Botolinum Toxin Retrospective Market Scenario by Region
3.1 Global Dermal Filler and Botolinum Toxin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dermal Filler and Botolinum Toxin Global Dermal Filler and Botolinum Toxin Sales by Region: 2019-2030
3.2.1 Global Dermal Filler and Botolinum Toxin Sales by Region: 2019-2024
3.2.2 Global Dermal Filler and Botolinum Toxin Sales by Region: 2025-2030
3.3 Global Dermal Filler and Botolinum Toxin Global Dermal Filler and Botolinum Toxin Revenue by Region: 2019-2030
3.3.1 Global Dermal Filler and Botolinum Toxin Revenue by Region: 2019-2024
3.3.2 Global Dermal Filler and Botolinum Toxin Revenue by Region: 2025-2030
3.4 North America Dermal Filler and Botolinum Toxin Market Facts & Figures by Country
3.4.1 North America Dermal Filler and Botolinum Toxin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dermal Filler and Botolinum Toxin Sales by Country (2019-2030)
3.4.3 North America Dermal Filler and Botolinum Toxin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dermal Filler and Botolinum Toxin Market Facts & Figures by Country
3.5.1 Europe Dermal Filler and Botolinum Toxin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dermal Filler and Botolinum Toxin Sales by Country (2019-2030)
3.5.3 Europe Dermal Filler and Botolinum Toxin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dermal Filler and Botolinum Toxin Market Facts & Figures by Country
3.6.1 Asia Pacific Dermal Filler and Botolinum Toxin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dermal Filler and Botolinum Toxin Sales by Country (2019-2030)
3.6.3 Asia Pacific Dermal Filler and Botolinum Toxin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dermal Filler and Botolinum Toxin Market Facts & Figures by Country
3.7.1 Latin America Dermal Filler and Botolinum Toxin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dermal Filler and Botolinum Toxin Sales by Country (2019-2030)
3.7.3 Latin America Dermal Filler and Botolinum Toxin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dermal Filler and Botolinum Toxin Market Facts & Figures by Country
3.8.1 Middle East and Africa Dermal Filler and Botolinum Toxin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dermal Filler and Botolinum Toxin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dermal Filler and Botolinum Toxin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dermal Filler and Botolinum Toxin Sales by Type (2019-2030)
4.1.1 Global Dermal Filler and Botolinum Toxin Sales by Type (2019-2024)
4.1.2 Global Dermal Filler and Botolinum Toxin Sales by Type (2025-2030)
4.1.3 Global Dermal Filler and Botolinum Toxin Sales Market Share by Type (2019-2030)
4.2 Global Dermal Filler and Botolinum Toxin Revenue by Type (2019-2030)
4.2.1 Global Dermal Filler and Botolinum Toxin Revenue by Type (2019-2024)
4.2.2 Global Dermal Filler and Botolinum Toxin Revenue by Type (2025-2030)
4.2.3 Global Dermal Filler and Botolinum Toxin Revenue Market Share by Type (2019-2030)
4.3 Global Dermal Filler and Botolinum Toxin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dermal Filler and Botolinum Toxin Sales by Application (2019-2030)
5.1.1 Global Dermal Filler and Botolinum Toxin Sales by Application (2019-2024)
5.1.2 Global Dermal Filler and Botolinum Toxin Sales by Application (2025-2030)
5.1.3 Global Dermal Filler and Botolinum Toxin Sales Market Share by Application (2019-2030)
5.2 Global Dermal Filler and Botolinum Toxin Revenue by Application (2019-2030)
5.2.1 Global Dermal Filler and Botolinum Toxin Revenue by Application (2019-2024)
5.2.2 Global Dermal Filler and Botolinum Toxin Revenue by Application (2025-2030)
5.2.3 Global Dermal Filler and Botolinum Toxin Revenue Market Share by Application (2019-2030)
5.3 Global Dermal Filler and Botolinum Toxin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Dermal Filler and Botolinum Toxin Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Galderma
6.2.1 Galderma Corporation Information
6.2.2 Galderma Description and Business Overview
6.2.3 Galderma Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Galderma Dermal Filler and Botolinum Toxin Product Portfolio
6.2.5 Galderma Recent Developments/Updates
6.3 Merz Pharma GmbH & Co. KGaA
6.3.1 Merz Pharma GmbH & Co. KGaA Corporation Information
6.3.2 Merz Pharma GmbH & Co. KGaA Description and Business Overview
6.3.3 Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Product Portfolio
6.3.5 Merz Pharma GmbH & Co. KGaA Recent Developments/Updates
6.4 Anika Therapeutics
6.4.1 Anika Therapeutics Corporation Information
6.4.2 Anika Therapeutics Description and Business Overview
6.4.3 Anika Therapeutics Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Anika Therapeutics Dermal Filler and Botolinum Toxin Product Portfolio
6.4.5 Anika Therapeutics Recent Developments/Updates
6.5 Suneva Medical
6.5.1 Suneva Medical Corporation Information
6.5.2 Suneva Medical Description and Business Overview
6.5.3 Suneva Medical Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Suneva Medical Dermal Filler and Botolinum Toxin Product Portfolio
6.5.5 Suneva Medical Recent Developments/Updates
6.6 Contura
6.6.1 Contura Corporation Information
6.6.2 Contura Description and Business Overview
6.6.3 Contura Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Contura Dermal Filler and Botolinum Toxin Product Portfolio
6.6.5 Contura Recent Developments/Updates
6.7 HUGEL
6.6.1 HUGEL Corporation Information
6.6.2 HUGEL Description and Business Overview
6.6.3 HUGEL Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HUGEL Dermal Filler and Botolinum Toxin Product Portfolio
6.7.5 HUGEL Recent Developments/Updates
6.8 Grex Pharma
6.8.1 Grex Pharma Corporation Information
6.8.2 Grex Pharma Description and Business Overview
6.8.3 Grex Pharma Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Grex Pharma Dermal Filler and Botolinum Toxin Product Portfolio
6.8.5 Grex Pharma Recent Developments/Updates
6.9 Daewoong Pharmaceuticals
6.9.1 Daewoong Pharmaceuticals Corporation Information
6.9.2 Daewoong Pharmaceuticals Description and Business Overview
6.9.3 Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Product Portfolio
6.9.5 Daewoong Pharmaceuticals Recent Developments/Updates
6.10 Medy-Tox
6.10.1 Medy-Tox Corporation Information
6.10.2 Medy-Tox Description and Business Overview
6.10.3 Medy-Tox Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Medy-Tox Dermal Filler and Botolinum Toxin Product Portfolio
6.10.5 Medy-Tox Recent Developments/Updates
6.11 TEOXANE Laboratories
6.11.1 TEOXANE Laboratories Corporation Information
6.11.2 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Description and Business Overview
6.11.3 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Product Portfolio
6.11.5 TEOXANE Laboratories Recent Developments/Updates
6.12 SciVision Biotech
6.12.1 SciVision Biotech Corporation Information
6.12.2 SciVision Biotech Dermal Filler and Botolinum Toxin Description and Business Overview
6.12.3 SciVision Biotech Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 SciVision Biotech Dermal Filler and Botolinum Toxin Product Portfolio
6.12.5 SciVision Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dermal Filler and Botolinum Toxin Industry Chain Analysis
7.2 Dermal Filler and Botolinum Toxin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dermal Filler and Botolinum Toxin Production Mode & Process
7.4 Dermal Filler and Botolinum Toxin Sales and Marketing
7.4.1 Dermal Filler and Botolinum Toxin Sales Channels
7.4.2 Dermal Filler and Botolinum Toxin Distributors
7.5 Dermal Filler and Botolinum Toxin Customers
8 Dermal Filler and Botolinum Toxin Market Dynamics
8.1 Dermal Filler and Botolinum Toxin Industry Trends
8.2 Dermal Filler and Botolinum Toxin Market Drivers
8.3 Dermal Filler and Botolinum Toxin Market Challenges
8.4 Dermal Filler and Botolinum Toxin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Dermal Filler and Botolinum Toxin Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Dermal Filler and Botolinum Toxin Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Dermal Filler and Botolinum Toxin Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Dermal Filler and Botolinum Toxin Sales (K MT) of Key Manufacturers (2019-2024)
    Table 5. Global Dermal Filler and Botolinum Toxin Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Dermal Filler and Botolinum Toxin Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Dermal Filler and Botolinum Toxin Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Dermal Filler and Botolinum Toxin Average Price (USD/MT) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Dermal Filler and Botolinum Toxin, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Dermal Filler and Botolinum Toxin, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Dermal Filler and Botolinum Toxin, Product Type & Application
    Table 12. Global Key Manufacturers of Dermal Filler and Botolinum Toxin, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Dermal Filler and Botolinum Toxin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermal Filler and Botolinum Toxin as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Dermal Filler and Botolinum Toxin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Dermal Filler and Botolinum Toxin Sales by Region (2019-2024) & (K MT)
    Table 18. Global Dermal Filler and Botolinum Toxin Sales Market Share by Region (2019-2024)
    Table 19. Global Dermal Filler and Botolinum Toxin Sales by Region (2025-2030) & (K MT)
    Table 20. Global Dermal Filler and Botolinum Toxin Sales Market Share by Region (2025-2030)
    Table 21. Global Dermal Filler and Botolinum Toxin Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Region (2019-2024)
    Table 23. Global Dermal Filler and Botolinum Toxin Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Region (2025-2030)
    Table 25. North America Dermal Filler and Botolinum Toxin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Dermal Filler and Botolinum Toxin Sales by Country (2019-2024) & (K MT)
    Table 27. North America Dermal Filler and Botolinum Toxin Sales by Country (2025-2030) & (K MT)
    Table 28. North America Dermal Filler and Botolinum Toxin Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Dermal Filler and Botolinum Toxin Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Dermal Filler and Botolinum Toxin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Dermal Filler and Botolinum Toxin Sales by Country (2019-2024) & (K MT)
    Table 32. Europe Dermal Filler and Botolinum Toxin Sales by Country (2025-2030) & (K MT)
    Table 33. Europe Dermal Filler and Botolinum Toxin Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Dermal Filler and Botolinum Toxin Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Dermal Filler and Botolinum Toxin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Dermal Filler and Botolinum Toxin Sales by Region (2019-2024) & (K MT)
    Table 37. Asia Pacific Dermal Filler and Botolinum Toxin Sales by Region (2025-2030) & (K MT)
    Table 38. Asia Pacific Dermal Filler and Botolinum Toxin Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Dermal Filler and Botolinum Toxin Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Dermal Filler and Botolinum Toxin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Dermal Filler and Botolinum Toxin Sales by Country (2019-2024) & (K MT)
    Table 42. Latin America Dermal Filler and Botolinum Toxin Sales by Country (2025-2030) & (K MT)
    Table 43. Latin America Dermal Filler and Botolinum Toxin Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Dermal Filler and Botolinum Toxin Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Dermal Filler and Botolinum Toxin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Dermal Filler and Botolinum Toxin Sales by Country (2019-2024) & (K MT)
    Table 47. Middle East & Africa Dermal Filler and Botolinum Toxin Sales by Country (2025-2030) & (K MT)
    Table 48. Middle East & Africa Dermal Filler and Botolinum Toxin Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Dermal Filler and Botolinum Toxin Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Dermal Filler and Botolinum Toxin Sales (K MT) by Type (2019-2024)
    Table 51. Global Dermal Filler and Botolinum Toxin Sales (K MT) by Type (2025-2030)
    Table 52. Global Dermal Filler and Botolinum Toxin Sales Market Share by Type (2019-2024)
    Table 53. Global Dermal Filler and Botolinum Toxin Sales Market Share by Type (2025-2030)
    Table 54. Global Dermal Filler and Botolinum Toxin Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Dermal Filler and Botolinum Toxin Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Type (2019-2024)
    Table 57. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Type (2025-2030)
    Table 58. Global Dermal Filler and Botolinum Toxin Price (USD/MT) by Type (2019-2024)
    Table 59. Global Dermal Filler and Botolinum Toxin Price (USD/MT) by Type (2025-2030)
    Table 60. Global Dermal Filler and Botolinum Toxin Sales (K MT) by Application (2019-2024)
    Table 61. Global Dermal Filler and Botolinum Toxin Sales (K MT) by Application (2025-2030)
    Table 62. Global Dermal Filler and Botolinum Toxin Sales Market Share by Application (2019-2024)
    Table 63. Global Dermal Filler and Botolinum Toxin Sales Market Share by Application (2025-2030)
    Table 64. Global Dermal Filler and Botolinum Toxin Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Dermal Filler and Botolinum Toxin Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Application (2019-2024)
    Table 67. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Application (2025-2030)
    Table 68. Global Dermal Filler and Botolinum Toxin Price (USD/MT) by Application (2019-2024)
    Table 69. Global Dermal Filler and Botolinum Toxin Price (USD/MT) by Application (2025-2030)
    Table 70. Allergan Corporation Information
    Table 71. Allergan Description and Business Overview
    Table 72. Allergan Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 73. Allergan Dermal Filler and Botolinum Toxin Product
    Table 74. Allergan Recent Developments/Updates
    Table 75. Galderma Corporation Information
    Table 76. Galderma Description and Business Overview
    Table 77. Galderma Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 78. Galderma Dermal Filler and Botolinum Toxin Product
    Table 79. Galderma Recent Developments/Updates
    Table 80. Merz Pharma GmbH & Co. KGaA Corporation Information
    Table 81. Merz Pharma GmbH & Co. KGaA Description and Business Overview
    Table 82. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 83. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Product
    Table 84. Merz Pharma GmbH & Co. KGaA Recent Developments/Updates
    Table 85. Anika Therapeutics Corporation Information
    Table 86. Anika Therapeutics Description and Business Overview
    Table 87. Anika Therapeutics Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 88. Anika Therapeutics Dermal Filler and Botolinum Toxin Product
    Table 89. Anika Therapeutics Recent Developments/Updates
    Table 90. Suneva Medical Corporation Information
    Table 91. Suneva Medical Description and Business Overview
    Table 92. Suneva Medical Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 93. Suneva Medical Dermal Filler and Botolinum Toxin Product
    Table 94. Suneva Medical Recent Developments/Updates
    Table 95. Contura Corporation Information
    Table 96. Contura Description and Business Overview
    Table 97. Contura Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 98. Contura Dermal Filler and Botolinum Toxin Product
    Table 99. Contura Recent Developments/Updates
    Table 100. HUGEL Corporation Information
    Table 101. HUGEL Description and Business Overview
    Table 102. HUGEL Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 103. HUGEL Dermal Filler and Botolinum Toxin Product
    Table 104. HUGEL Recent Developments/Updates
    Table 105. Grex Pharma Corporation Information
    Table 106. Grex Pharma Description and Business Overview
    Table 107. Grex Pharma Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 108. Grex Pharma Dermal Filler and Botolinum Toxin Product
    Table 109. Grex Pharma Recent Developments/Updates
    Table 110. Daewoong Pharmaceuticals Corporation Information
    Table 111. Daewoong Pharmaceuticals Description and Business Overview
    Table 112. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 113. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Product
    Table 114. Daewoong Pharmaceuticals Recent Developments/Updates
    Table 115. Medy-Tox Corporation Information
    Table 116. Medy-Tox Description and Business Overview
    Table 117. Medy-Tox Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 118. Medy-Tox Dermal Filler and Botolinum Toxin Product
    Table 119. Medy-Tox Recent Developments/Updates
    Table 120. TEOXANE Laboratories Corporation Information
    Table 121. TEOXANE Laboratories Description and Business Overview
    Table 122. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 123. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Product
    Table 124. TEOXANE Laboratories Recent Developments/Updates
    Table 125. SciVision Biotech Corporation Information
    Table 126. SciVision Biotech Description and Business Overview
    Table 127. SciVision Biotech Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 128. SciVision Biotech Dermal Filler and Botolinum Toxin Product
    Table 129. SciVision Biotech Recent Developments/Updates
    Table 130. Key Raw Materials Lists
    Table 131. Raw Materials Key Suppliers Lists
    Table 132. Dermal Filler and Botolinum Toxin Distributors List
    Table 133. Dermal Filler and Botolinum Toxin Customers List
    Table 134. Dermal Filler and Botolinum Toxin Market Trends
    Table 135. Dermal Filler and Botolinum Toxin Market Drivers
    Table 136. Dermal Filler and Botolinum Toxin Market Challenges
    Table 137. Dermal Filler and Botolinum Toxin Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Dermal Filler and Botolinum Toxin
    Figure 2. Global Dermal Filler and Botolinum Toxin Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Dermal Filler and Botolinum Toxin Market Share by Type in 2023 & 2030
    Figure 4. Hyaluronic Acid Based Fillers Product Picture
    Figure 5. Non-Hyaluronic Acid Based Fillers Product Picture
    Figure 6. Botulinum Toxin Product Picture
    Figure 7. Global Dermal Filler and Botolinum Toxin Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Dermal Filler and Botolinum Toxin Market Share by Application in 2023 & 2030
    Figure 9. Aesthetic Restoration
    Figure 10. Wrinkle Reduction
    Figure 11. Global Dermal Filler and Botolinum Toxin Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Dermal Filler and Botolinum Toxin Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Dermal Filler and Botolinum Toxin Sales (2019-2030) & (K MT)
    Figure 14. Global Dermal Filler and Botolinum Toxin Average Price (USD/MT) & (2019-2030)
    Figure 15. Dermal Filler and Botolinum Toxin Report Years Considered
    Figure 16. Dermal Filler and Botolinum Toxin Sales Share by Manufacturers in 2023
    Figure 17. Global Dermal Filler and Botolinum Toxin Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Dermal Filler and Botolinum Toxin Players: Market Share by Revenue in 2023
    Figure 19. Dermal Filler and Botolinum Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Dermal Filler and Botolinum Toxin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Dermal Filler and Botolinum Toxin Sales Market Share by Country (2019-2030)
    Figure 22. North America Dermal Filler and Botolinum Toxin Revenue Market Share by Country (2019-2030)
    Figure 23. U.S. Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Dermal Filler and Botolinum Toxin Sales Market Share by Country (2019-2030)
    Figure 26. Europe Dermal Filler and Botolinum Toxin Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Dermal Filler and Botolinum Toxin Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Dermal Filler and Botolinum Toxin Revenue Market Share by Region (2019-2030)
    Figure 34. China Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Taiwan Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Philippines Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Dermal Filler and Botolinum Toxin Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Dermal Filler and Botolinum Toxin Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Dermal Filler and Botolinum Toxin Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Dermal Filler and Botolinum Toxin Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. U.A.E Dermal Filler and Botolinum Toxin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Dermal Filler and Botolinum Toxin by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Dermal Filler and Botolinum Toxin by Type (2019-2030)
    Figure 56. Global Dermal Filler and Botolinum Toxin Price (USD/MT) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Dermal Filler and Botolinum Toxin by Application (2019-2030)
    Figure 58. Global Revenue Market Share of Dermal Filler and Botolinum Toxin by Application (2019-2030)
    Figure 59. Global Dermal Filler and Botolinum Toxin Price (USD/MT) by Application (2019-2030)
    Figure 60. Dermal Filler and Botolinum Toxin Value Chain
    Figure 61. Dermal Filler and Botolinum Toxin Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Paroxetine Hydrochloride Tablet Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36M7629
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Felodipine Sustained-Release Tablet Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36A7630
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Sertraline Hydrochloride Tablet Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25H7597
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Escitalopram Oxalate Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-11E7869
Thu Mar 28 00:00:00 UTC 2024

Add to Cart